19 June 2013
Keywords: fda, ok, liquid, version, synagis, biotechnology, firm
Article | 02 August 2004
US biotechnology firm MedImmune has received US Food and DrugAdministration approval for a new liquid formulation of its
anti-infective Synagis ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
2 August 2004
26 July 2004
18 June 2013
© 2013 thepharmaletter.com